Malaria & Neglected Tropical Diseases

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS The health of women and children is threatened by a treatable disease Pregnant women, teenage girls and children remain disproportionately vulnerable to malaria. <strong>Malaria</strong> is one of the world’s oldest, deadliest diseases, stealing young futures and claiming the life of a child every minute, despite being treatable, preventable and beatable. The heavy human cost of malaria can be measured in the number of each and every life lost and the many more that are diminished, with the latest World <strong>Malaria</strong> Report revealing 241 million cases and 627,000 deaths worldwide in 2020 - the highest number of deaths in nearly a decade. <strong>Malaria</strong> deaths are increasing Tragically, millions of pregnant women, adolescent girls and young children remain disproportionately vulnerable to malaria, with the disease cited as the third highest cause of death in teenage girls aged 15-19 in sub-Saharan Africa in 2019. Despite substantial efforts to continue malaria services during COVID-19, disruptions resulted in an additional 47,000 malaria deaths in 2020 and, with the impacts of the pandemic ongoing, so too are disruptions to healthcare. The pandemic has also weakened economies and exacerbated alreadyfragile health systems which paints an even darker picture for the health of women and children going forward. Limited access to preventable treatment In 2020, a staggering 11.6 million pregnant women contracted malaria across sub-Saharan Africa, and more than two-thirds of eligible women across 33 African countries did not receive the full course of preventive malaria treatment (IPTp-SP) recommended by the World Health Organization. <strong>Malaria</strong> in pregnancy has been associated with maternal anaemia, exposing the mother to an increased risk of death before, during and after childbirth. The dangers are also substantial for the newborn child, including low birth weight which can impact growth and cognitive development. Achieving key global malaria targets One third of the Global Fund to Fight AIDS, Tuberculosis and <strong>Malaria</strong>’s investment goes towards building inclusive health systems, ensuring that women and girls have access to quality health services for malaria and sexual and reproductive health. This helps boost progress toward key global malaria targets and supports many of the Sustainable Development Goals including fighting poverty, improving gender equality and universal health. The Global Fund’s seventh replenishment target this Autumn is to raise at least USD 18 billion to fight the three diseases, which would save 20 million lives, cut the malaria death rate by 64% and build a healthier, more equitable world, making the UK’s financial commitment to ending malaria more critical than ever. <strong>Malaria</strong> is a disease that this generation can end, but only if we act now. WRITTEN BY James Whiting CEO, <strong>Malaria</strong> No More UK Genuine intersectoral collaboration needed to achieve better progress against vector-borne NTDs WRITTEN BY Ashok Moloo Information Officer, WHO Department of Control of <strong>Neglected</strong> <strong>Tropical</strong> <strong>Diseases</strong> WRITTEN BY Dr Raman Velayudhan Head, Veterinary Public Health, Vector Control and Environment, WHO Department of Control of <strong>Neglected</strong> <strong>Tropical</strong> <strong>Diseases</strong> This article was originally published on the World Health Organization’s website. Scan the QR code to access the original article The world needs to work better and collaborate with sectors beyond health to implement the Global Vector Control Response 2017–2030 (GVCR). The silent spread of vectors over the years means more countries are now exposed to arboviral diseases, with human activities facilitating their survival and propagation. “It is time that vector control programmes work jointly with city planners, environmentalists, engineers and sectors that manage water and sanitation,” says a leading expert during a WHO-hosted webinar on ‘Reducing the burden and threat of vector-borne diseases to achieve the NTD road map targets.’ “We face the prospect of seven out of 10 people living in cities and urban areas globally by 2050.” Focussing on prevention “One of the things which is critical as we build out future cities … we really need to do better in the area of prevention … reducing the habitats of all mosquito species,” says Steve Lindsay, panellist and former Professor at Durham University, United Kingdom. This implies reducing the breeding sites for Aedes mosquitoes that transmit vector-borne diseases such as dengue, chikungunya, yellow fever and Zika. This can be done by enhancing access to piped water, constructing houses with built-in screens to block mosquito entry, clearing waste, improving drainage and keeping the environment clean. More than half the world’s population is at risk of infection from vector-borne diseases. Challenges to meet targets While the GVCR is on track for some activities, amounting to an almost 10% reduction in global mortality over the past five years, for many other activities targets have not been reached. A progress report outlining achievements and challenges will be submitted to the 75th World Health Assembly in May 2022. Assessing global risk More than half the world’s population is at risk of infection from vector-borne diseases, especially dengue, leishmaniasis and malaria. Vectors are responsible for transmitting many neglected tropical diseases, mostly among the poorest populations where there is a lack of access to adequate housing, safe drinking-water and sanitation. During the past two decades, many vector-borne diseases have emerged or re-emerged, spreading to new parts of the world. Dengue alone has increased six-fold since 2000 and it affects over 130 countries and still there are no effective drugs, vaccines and sustainable vector control tools, making it more neglected. Other factors, such as environmental changes, increased international travel and trade, changes in agricultural practices and rapid, unplanned urbanisation have facilitated the spread of many vectors worldwide. Current efforts to address the needs for better diagnostics, vaccines and sustainable innovative vector control interventions such as the use of Wolbachia, spatial repellents etc are encouraging new hope in the horizon to address the void and meet the goals set in the NTD roadmap 2021-2030. 06 MEDIAPLANET READ MORE AT GLOBALCAUSE.CO.UK

A PROMOTIONAL SUPPLEMENT DISTRIBUTED ON BEHALF OF MEDIAPLANET, WHICH TAKES SOLE RESPONSIBILITY FOR ITS CONTENTS We need to be more adaptable to control the resurgence of malaria spatially contextualised information. This can be delivered via different innovative systems. For example, in Equatorial Guinea, MCD is using a tablet application (CIMS) to collect and use field-level malaria control data at the household and individual levels. Meanwhile, in other countries, MCD is supporting the integration of major health information databases to a common platform. “Having a more efficient way of entering, processing and analysing data is a big benefit in the fight against malaria,” says Julie Niemczura, Senior Program Manager at MCD. “Real-time access to information shortens the feedback loop so that any deficiencies can be corrected immediately.” INTERVIEW WITH Guillermo García Senior Program Manager, Bioko Island <strong>Malaria</strong> Elimination Project, Medical Care Development In recent years, malaria cases have been on the rise. The disease transmission has changed — so the response to it must change too with a new, adaptive approach based on evidence and data. Image provided by MCDI An adaptive approach isn’t simply beneficial for controlling malaria. It can also promote sustainable health systems, strengthening their ability to respond rapidly and effectively to unforeseen challenges. INTERVIEW WITH Olivier Tresor Donfack Technical Coordinator, Bioko Island <strong>Malaria</strong> Elimination Project, Medical Care Development Paid for by Medical Care Development International Controlling malaria is — and has always been — a mammoth challenge. Decades after the first Global <strong>Malaria</strong> Eradication Programme was launched in 1955, this life-threatening disease still brings untold misery and death to many parts of the world. Indeed, malaria cases are on the increase. According to figures from the World Health Organization, there were 241 million cases in 2020 compared to 227 million in 2019. There are a number of reasons for this rise, says Guillermo García, Senior Program Manager, Bioko Island <strong>Malaria</strong> Elimination Project at MCD, a global public health non-profit providing interventions across several health areas. “There are challenges, for example drug and insecticide resistance,” he says. Understanding why there is a resurgence in malaria Climate variability may also be partly responsible for the resurgence, as warmer temperatures and increased rainfall make better breeding conditions for mosquitoes; plus, the behaviour of mosquitoes is changing. “In some areas, there is evidence that insects are biting earlier in the evening, before people are indoors or protected by bed nets,” says Olivier Tresor Donfack, Technical Coordinator, Bioko Island <strong>Malaria</strong> Elimination Project, MCD. To make matters worse, malaria control has faced huge funding constraints — and increased competition due to the global pandemic. This has hit resource-poor communities particularly hard as they face a disproportionate burden of illness, death, and declining economic productivity, welfare and wellbeing. Benefits of an adaptive evidence-based approach To effectively respond to the resurgence and ultimately achieve elimination, it’s imperative that funding for malaria control continues. “Of course, any tools that are proven to work should continue to be deployed,” says García. “But in this fight, there is often a need for more innovation and adaptation.” After all, when traditional methods of malaria control prove inadequate, new approaches must be found. This is why it’s important to adapt and optimise malaria control strategies through evidence-based decision making, based on the use of real-time Building local capacity with training and support Not all solutions have to be hi-tech. “In some health facilities, wall charts filled out by hand are a simple way to track trends,” says Niemczura. “But how ever health managers receive the information, it’s crucial that they know how to use the systems and interpret the data to affect positive outcomes.” This requires building local capacity with robust training and support, delivered via different institutional partners. An adaptive approach isn’t simply beneficial for controlling malaria. It can also promote sustainable health systems, strengthening their ability to respond rapidly and effectively to unforeseen challenges and emerging threats, such as the COVID-19 pandemic. “In Equatorial Guinea, a team that was fully trained to deliver clinical trials for malaria was quickly able to adapt to meet the demands of COVID-19,” remembers García. Yet despite the increase in malaria cases, it’s important to keep things in perspective. “The resurgence does not mean that control programmes are failing,” stresses Donfack. “In fact, we’re optimistic that trends will change — if programmes adopt adaptive control measures based on evidence and data.” INTERVIEW WITH Julie Niemczura Senior Program Manager, Medical Care Development WRITTEN BY Tony Greenway Find out more at mcd.org READ MORE AT GLOBALCAUSE.CO.UK MEDIAPLANET 07